Sample size re-estimation for pivotal clinical trials.

Contemporary Clinical Trials
Yi Liu, Heng Xu

Abstract

It is well known that if the hypothesis test is left unchanged, the Type I error rate may be inflated for sample size re-estimation (SSR) designs. To address this issue, three main approaches have been proposed in the literature: combination test, conditional error and conventional test with sample size increase in the allowable region (AR) only. These three seemingly different approaches are in fact connected. For each combination test, there is a corresponding conditional error function and AR. Designing adaptation rules in this AR with conventional test guarantees the Type I error rate control but at the same time always leads to smaller power comparing to the corresponding combination test (or conditional error) approach. In cases where conventional test is still preferable, step-wise type adaptation rules that do not fully reside in the AR can be alternatively considered. We believe controversies in the statistical community on the efficiency comparisons between group sequential (GS) and SSR design stem partially from the misalignment of performance metrics and conditional versus unconditional evaluations. We advocate summary metrics, such as median, variance or tail probabilities of the sample size in addition to expectat...Continue Reading

References

Apr 21, 2001·Biometrics·W Lehmacher, G Wassmer
Mar 11, 2003·Statistics in Medicine·Tim Friede, Meinhard Kieser
Apr 2, 2004·Statistics in Medicine·Y H Joshua ChenK K Gordon Lan
Aug 3, 2004·Statistics in Medicine·Hans-Helge Müller, Helmut Schäfer
Apr 2, 2005·Statistics in Medicine·Biao Xing, Jitendra Ganju
Oct 13, 2005·Statistics in Medicine·Werner BrannathPeter Bauer
Oct 13, 2005·Statistics in Medicine·Peter Bauer, Franz Koenig
Sep 16, 2006·Biometrical Journal. Biometrische Zeitschrift·Tim Friede, Meinhard Kieser
Sep 16, 2006·Biometrical Journal. Biometrische Zeitschrift·Gernot Wassmer
Aug 4, 2007·Pharmaceutical Statistics·Werner BrannathPeter Bauer
Oct 6, 2007·Statistics in Medicine·Cyrus R MehtaWerner Brannath
Sep 2, 2008·Biometrics·Werner BrannathMartin Posch
Feb 12, 2009·Statistics in Medicine·Frank BretzMartin Posch
Apr 10, 2009·Biometrical Journal. Biometrische Zeitschrift·Michael A Proschan
Nov 23, 2011·Statistics in Medicine·Cyrus R Mehta, Stuart J Pocock
Jul 14, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·John Peter ZajicekUNKNOWN MUSEC Research Group
May 21, 2013·Statistics in Medicine·Ping GaoCyrus Mehta
Mar 18, 2015·Statistics in Medicine·Peter BauerGernot Wassmer
Jul 15, 2015·Statistics in Medicine·Christopher Jennison, Bruce W Turnbull
Nov 27, 2015·Pharmaceutical Statistics·Yi Liu, Mingxiu Hu
Feb 11, 2016·PloS One·Dominic MagirrMartin Posch
Oct 3, 2017·Contemporary Clinical Trials·Cong ChenArchie Tse
Mar 1, 2016·Therapeutic Innovation & Regulatory Science·Min LinEstelle Russek-Cohen
Nov 1, 2016·Therapeutic Innovation & Regulatory Science·Xiting YangGerry W Gray
Nov 20, 2018·Statistics in Medicine·Lu Cui, Lanju Zhang
Dec 5, 2018·Therapeutic Innovation & Regulatory Science·Alan HartfordCaroline Morgan
Jun 27, 2019·Journal of Biopharmaceutical Statistics·Xiaofei Bai, Qiqi Deng
Jul 2, 2019·Journal of Biopharmaceutical Statistics·Lu CuiSue Jane Wang
Jun 7, 2020·Contemporary Clinical Trials·Cong ChenQiqi Deng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.